HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
28 hedge funds and large institutions have $4.24M invested in Hepion Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
56% less capital invested
Capital invested by funds: $9.74M → $4.24M (-$5.5M)
Holders
28
Holding in Top 10
–
Calls
$145K
Puts
$11K
Top Buyers
| 1 | +$61.6K | |
| 2 | +$25.9K | |
| 3 | +$13K | |
| 4 |
Jane Street
New York
|
+$9.78K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.83K |
Top Sellers
| 1 | -$98.6K | |
| 2 | -$20.3K | |
| 3 | -$20K | |
| 4 |
Goldman Sachs
New York
|
-$19K |
| 5 |
JWM
JGP Wealth Management
Bend,
Oregon
|
-$17K |